Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Jun 25;321(24):2467.
doi: 10.1001/jama.2019.4963.

Dietary Supplements for Brain Health

A David Smith  1 , Helga Refsum  2 , Joshua W Miller  3
Affiliations
Comment

Dietary Supplements for Brain Health

A David Smith et al. JAMA. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Hellmuth reported receiving a grant from the National Institute of Mental Health. Dr Rabinovici reported receiving research support from Avid Radiopharmaceuticals, Eli Lilly, GE Healthcare, and Life Molecular Imaging; receiving consulting honoraria from Axon Neurosciences, Eisai, Genentech, Merck, and Roche; and being an associate editor for JAMA Neurology. Dr Miller reported receiving research support from the Quest Diagnostics Dementia Pathway Collaboration, Cornell University, and The Bluefield Project to Cure Frontotemporal Dementia; serving as the medical director for the John Douglas French Foundation; serving as the scientific director for the Tau Consortium; serving as the director and on the Medical Advisory Board of the Larry L. Hillblom Foundation; being past president of the International Society of Frontotemporal Dementia; and receiving grants from the National Institute on Aging.

Comment in

Comment on

References

    1. Hellmuth J, Rabinovici GD, Miller BL. The rise of pseudomedicine for dementia and brain health. JAMA. 2019;321(6):543–544. doi:10.1001/jama.2018.21560 - DOI - PMC - PubMed
    1. Douaud G, Refsum H, de Jager CA, et al. Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment. Proc Natl Acad Sci U S A. 2013;110(23):9523–9528. doi:10.1073/pnas.1301816110 - DOI - PMC - PubMed
    1. Servick K Another major drug candidate targeting the brain plaques of Alzheimer’s disease has failed. What’s left? Science. https://www.sciencemag.org/news/2019/03/another-major-drug-candidate-tar.... Published March 21, 2019. Accessed March 22, 2019.
    1. Langan RC, Goodbred AJ. Vitamin B12 deficiency: recognition and management. Am Fam Physician. 2017;96(6):384–389. - PubMed
    1. Butler M, Nelson VA, Davila H, et al. Over-the-counter supplement interventions to prevent cognitive decline, mild cognitive impairment, and clinical Alzheimer-type dementia: a systematic review. Ann Intern Med. 2018; 168(1):52–62. doi:10.7326/M17-1530 - DOI - PubMed